Puma Biotechnology, Inc. (PBYI) Q2 FY26 Earnings Call

$53.6 million Q2 net product revenue increased 27.6% sequentially, while 2026 revenue guidance rose to $205-$209 million. [4][25]

Q2 FY26 results, source: company transcript and SEC filings
QuarterQ2 FY26
Call date2026-08-06
Length32 minutes
EPS$0.16
Revenue$56.5M

What changed, guidance prior to now, analyst Q&A candor and the case for and against are part of Core.

All PBYI earnings ยท Back to PBYI overview

Transcript produced by Signals.AI from the company's own earnings call audio. Not personalized investment advice.